Condition: Chronic Coronary Syndrome · Sponsor: University of Thessaly
The aim of this study is to measure the levels of serum tryptase and correlate them with the severity of coronary artery disease in study population. In addition, it will evaluate the usability of tryptase levels as a prognostic biomarker for future cardiovascular events.
This description comes directly from the study's public registry record.
Fotios Skoufis, MD Medicine · +306981088650 · fskoufis@hotmail.com
Always discuss trial participation with your own doctor first.
| 417 Military Hospital NIMTS | Athens, Attica, Greece | Recruiting |
| Larisa University Hospital | Larissa, Thessaly, Greece | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06958016